Literature DB >> 10393951

IL-4 enhances proliferation and mediator release in mature human mast cells.

S C Bischoff1, G Sellge, A Lorentz, W Sebald, R Raab, M P Manns.   

Abstract

Tissue mast cells (MC) are recognized as key effector cells of immediate-type allergic reactions releasing inflammatory mediators and cytokines on stimulation with antigen, but they also might be involved in IgE-independent inflammatory and tissue repair processes. The mechanism of human MC regulation in tissue is not fully understood. Here, we show that IL-4, in synergy with stem cell factor (SCF), regulates the function of purified human MC isolated from intestinal tissue. Whereas SCF induced only marginal proliferation of MC cultured in vitro up to 4 weeks, addition of IL-4 and SCF strongly increased the proliferation rate. Moreover, IL-4, which by itself had no visible effect on human MC, enhanced the release of histamine, leukotriene C4, and IL-5 in MC triggered by IgE receptor crosslinking. The IL-4 effects occurred in a dose-dependent fashion (ED50 = 100 pg/ml) and could be totally blocked by a competitive IL-4 receptor antagonist. Our data indicate that IL-4 is an important regulator of human MC function and suggest that mature MC retain the capacity to proliferate in a particular tissue environment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10393951      PMCID: PMC22191          DOI: 10.1073/pnas.96.14.8080

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Human intestinal mast cells produce IL-5 in vitro upon IgE receptor cross-linking and in vivo in the course of intestinal inflammatory disease.

Authors:  A Lorentz; S Schwengberg; C Mierke; M P Manns; S C Bischoff
Journal:  Eur J Immunol       Date:  1999-05       Impact factor: 5.532

2.  IL-4 enhances IL-3 and IL-8 gene expression in a human leukemic mast cell line.

Authors:  M G Buckley; C M Williams; J Thompson; P Pryor; K Ray; J H Butterfield; J W Coleman
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

Review 3.  Biology of human TH1 and TH2 cells.

Authors:  S Romagnani
Journal:  J Clin Immunol       Date:  1995-05       Impact factor: 8.317

4.  Effects of T-helper 2-type cytokines, interleukin-3 (IL-3), IL-4, IL-5, and IL-6 on the survival of cultured human mast cells.

Authors:  M Yanagida; H Fukamachi; K Ohgami; T Kuwaki; H Ishii; H Uzumaki; K Amano; T Tokiwa; H Mitsui; H Saito; Y Iikura; T Ishizaka; T Nakahata
Journal:  Blood       Date:  1995-11-15       Impact factor: 22.113

5.  Stem-cell factor, the kit ligand, induces direct degranulation of rat peritoneal mast cells in vitro and in vivo: dependence of the in vitro effect on period of culture and comparisons of stem-cell factor with other mast cell-activating agents.

Authors:  A M Taylor; S J Galli; J W Coleman
Journal:  Immunology       Date:  1995-11       Impact factor: 7.397

6.  Design of human interleukin-4 antagonists inhibiting interleukin-4-dependent and interleukin-13-dependent responses in T-cells and B-cells with high efficiency.

Authors:  H P Tony; B J Shen; P Reusch; W Sebald
Journal:  Eur J Biochem       Date:  1994-10-15

7.  Stimulation of partial development of human mast cells by supernatant fluid from mouse fibroblast cultures.

Authors:  A M Dvorak; H Mitsui; T Ishizaka
Journal:  Clin Exp Allergy       Date:  1994-07       Impact factor: 5.018

8.  Serum levels of soluble IL-2R, IL-4, and soluble Fc epsilon RII in adult bronchial asthma.

Authors:  K Matsumoto; F Taki; M Miura; M Matsuzaki; K Takagi
Journal:  Chest       Date:  1994-03       Impact factor: 9.410

9.  Interleukin 4 down-regulates expression of c-kit and autocrine stem cell factor in human colorectal carcinoma cells.

Authors:  H Lahm; P Amstad; A Yilmaz; Z Borbenyi; J Wyniger; J R Fischer; L Suardet; J C Givel; N Odartchenko
Journal:  Cell Growth Differ       Date:  1995-09

10.  Inhibition of stem cell factor dependent formation of human mast cells by interleukin-3 and interleukin-4.

Authors:  C Sillaber; W R Sperr; H Agis; E Spanblöchl; K Lechner; P Valent
Journal:  Int Arch Allergy Immunol       Date:  1994-11       Impact factor: 2.749

View more
  48 in total

1.  IL-4 and -5 prime human mast cells for different profiles of IgE-dependent cytokine production.

Authors:  H Ochi; N H De Jesus; F H Hsieh; K F Austen; J A Boyce
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

Review 2.  Mast cells and inflammation.

Authors:  Theoharis C Theoharides; Konstantinos-Dionysios Alysandratos; Asimenia Angelidou; Danae-Anastasia Delivanis; Nikolaos Sismanopoulos; Bodi Zhang; Shahrzad Asadi; Magdalini Vasiadi; Zuyi Weng; Alexandra Miniati; Dimitrios Kalogeromitros
Journal:  Biochim Biophys Acta       Date:  2010-12-23

3.  The RgpA-Kgp proteinase-adhesin complexes of Porphyromonas gingivalis Inactivate the Th2 cytokines interleukin-4 and interleukin-5.

Authors:  Vivian Tam; Neil M O'Brien-Simpson; Yu-Yen Chen; Colin J Sanderson; Beverley Kinnear; Eric C Reynolds
Journal:  Infect Immun       Date:  2009-01-21       Impact factor: 3.441

4.  Selective expression of histamine receptors H1R, H2R, and H4R, but not H3R, in the human intestinal tract.

Authors:  L E Sander; A Lorentz; G Sellge; M Coëffier; M Neipp; T Veres; T Frieling; P N Meier; M P Manns; S C Bischoff
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

Review 5.  Signal transduction and chemotaxis in mast cells.

Authors:  Petr Draber; Ivana Halova; Iva Polakovicova; Toshiaki Kawakami
Journal:  Eur J Pharmacol       Date:  2015-05-02       Impact factor: 4.432

6.  Growth, phenotype, and function of human intestinal mast cells are tightly regulated by transforming growth factor beta1.

Authors:  T Gebhardt; A Lorentz; F Detmer; C Trautwein; H Bektas; M P Manns; S C Bischoff
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

Review 7.  Development, migration, and survival of mast cells.

Authors:  Yoshimichi Okayama; Toshiaki Kawakami
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

8.  The antigen presentation function of bone marrow-derived mast cells is spatiotemporally restricted to a subset expressing high levels of cell surface FcepsilonRI and MHC II.

Authors:  Jian Gong; Ning-Sun Yang; Michael Croft; I-Chun Weng; Liangwu Sun; Fu-Tong Liu; Swey-Shen Chen
Journal:  BMC Immunol       Date:  2010-06-30       Impact factor: 3.615

Review 9.  Physiological and pathophysiological functions of intestinal mast cells.

Authors:  Stephan C Bischoff
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

10.  Honeybee venom secretory phospholipase A2 induces leukotriene production but not histamine release from human basophils.

Authors:  F B Mustafa; F S P Ng; T H Nguyen; L H K Lim
Journal:  Clin Exp Immunol       Date:  2007-11-14       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.